Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Federica Carloni"'
Autor:
Giovanna Cavallo, Hirotsugu Kenmotsu, Federica Carloni, Emanuela Scarpi, Raffaele Califano, Marco Angelo Burgio, Claudia Casanova, Alberto Bongiovanni, Seber Selcuk, Monica Di Battista, Kurup Roopa, Giulio Metro, Wakuda Kazushige, Giovenzio Genestreti, Taner Korkmaz, Marcello Tiseo
Publikováno v:
Clinical Lung Cancer. 16:e223-e228
Small-cell lung cancer has a high chemotherapeutic sensitivity but with disappointing outcome results. Patients with “sensitive disease” are those who respond to treatment with a long relapse-free interval (RFI): in these cases rechallenge with f
Autor:
Fabrizio Drudi, Maximilian Papi, Paola Tombesi, Cinzia Castellani, Federica Carloni, Davide Tassinari, Luigi Lazzari-Agli, Sergio Sartori
Publikováno v:
Oncology. 80:350-358
Background: To assess the efficacy and safety of bevacizumab-containing regimens in the treatment of advanced, chemotherapy-naive, non-squamous non-small cell lung cancer (NSCLC) on the basis of the two registrative trials [ECOG E4599 trial and BO177
Autor:
Federica Carloni, Sergio Sartori, Emiliano Tamburini, Paola Tombesi, Luigi Lazzari Agli, Carlotta Santelmo, Davide Tassinari
Publikováno v:
Reviews on Recent Clinical Trials. 4:27-33
In the last 10 years the medical approach to platinum-resistant Non Small Cell Lung Cancer (NSCLC) has radically changed, passing from a lack of evidence of any primary treatment against the tumor, to the identification of chemotherapy or EGFR inhibi
Autor:
Paola Tombesi, Emanuela Scarpi, Cinzia Castellani, Fabrizio Drudi, Davide Tassinari, Federica Carloni, Sergio Sartori, Luigi Lazzari-Agli
Publikováno v:
American journal of clinical oncology. 35(6)
BACKGROUND To assess the role of the novel second-line treatments in nonsmall cell lung cancer (NSCLC). METHODS A systematic review of the literature with meta-analysis of phase III randomized clinical trials (RCTs) was independently performed by 3 a
Autor:
Davide, Tassinari, Fabrizio, Drudi, Federica, Carloni, Cinzia, Possenti, Carlotta, Santelmo, Cinzia, Castellani
Publikováno v:
Recenti progressi in medicina. 102(5)
Neuropathic pain is usually considered an "hard pain" both for the intrinsic difficulties in a correct diagnosis, and for the modest efficacy of the most part of conventional treatments. The most frequently used drugs in clinical practice are tricycl
Autor:
Davide, Tassinari, Fabrizio, Drudi, Federica, Carloni, Cinzia, Castellani, Emanuela, Scarpi, Marco, Maltoni
Publikováno v:
Recenti progressi in medicina. 100(12)
Although oral morphine is the gold standard in the front-line approach to moderate-severe cancer pain, transdermal opiates are largely used in clinical practice. Aims of our work were to review the evidences of literature supporting these different h
Autor:
Davide, Tassinari, Emiliano, Tamburini, Federica, Carloni, Stefania, Nicoletti, Alberto, Ravaioli
Publikováno v:
Recenti progressi in medicina. 100(2)
Aim of our work was to assess the role of prognostic and predictive factors in patients to be treated with II and III line chemotherapy in metastatic colorectal cancer.All the patients with metastatic colorectal cancer treated with at least one line
Autor:
Federica Carloni, L. Stocchi, Claudio Ridolfi, M.C. Monterubbianesi, Fabrizio Drudi, Carlotta Santelmo, Davide Tassinari, E. Barzotti, Stefania Nicoletti, A. Affatato
Publikováno v:
Annals of Oncology. 25:iv472
Background: Recently many authors have hypothesized that early palliative care (EPC) in patients with cancer could improve survival, quality of life or symptoms control. To confirm this datum, we have recently completed a systematic review of literat
Autor:
Alessandra Affatato, Lorenzo Gianni, Alberto Ravaioli, Claudio Ridolfi, Luigi Veneroni, Fabrizio Drudi, Gabriele Donati, Davide Tassinari, Federica Carloni, Carlotta Santelmo, Emiliano Tamburini
Publikováno v:
Journal of Clinical Oncology. 30:342-342
342 Background: To assess the role of adjuvant treatments (AT), adjuvant chemotherapy (AC) and adjuvant chemo-radiotherapy (ACR) in resected pancreatic adenocarcinoma. Methods: A systematic review of literature in the MEDLINE and EMBASE data bases fr
Autor:
Fabrizio Drudi, Lorenzo Gianni, Manuela Fantini, Federica Carloni, Cinzia Castellani, Emiliano Tamburini, Davide Tassinari, Maximilian Papi, Alberto Ravaioli, Carlotta Santelmo
Publikováno v:
Journal of Clinical Oncology. 29:4042-4042
4042 Background: To assess the role of adjuvant treatments (AT; chemotherapy [AC] and/or chemo-radiotherapy [ACR]) in radically resected pancreatic cancer. Methods: A systematic review of literatur...